Effects of different concentrations of dexmedetomidine on basal ganglia neuronal activity (local field potentials) in Parkinson's disease.
Not yet recruiting
Phase of Trial: Phase IV
Latest Information Update: 07 Dec 2016
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 30 Nov 2016 Status changed from recruiting to not yet recruiting.
- 26 Oct 2016 New trial record